![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 42, 39722-39727, October 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
, and
**
From the
Department of Biochemistry, University of
Wisconsin, Madison, Wisconsin, 53706-1544 and the
§ Department of Chemistry, Texas A&M University,
College Station, Texas 77843-3012
Received for publication, July 10, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Carbamoyl-phosphate synthetase
catalyzes the production of carbamoyl phosphate through a reaction
mechanism requiring one molecule of bicarbonate, two molecules of
MgATP, and one molecule of glutamine. The enzyme from Escherichia
coli is composed of two polypeptide chains. The smaller of these
belongs to the Class I amidotransferase superfamily and contains all of
the necessary amino acid side chains required for the hydrolysis of
glutamine to glutamate and ammonia. Two homologous domains from the
larger subunit adopt conformations that are characteristic for members of the ATP-grasp superfamily. Each of these ATP-grasp domains contains
an active site responsible for binding one molecule of MgATP. High
resolution x-ray crystallographic analyses have shown that, remarkably,
the three active sites in the E. coli enzyme are connected
by a molecular tunnel of ~100 Å in total length. Here we describe
the high resolution x-ray crystallographic structure of the G359F
(small subunit) mutant protein of carbamoyl phosphate synthetase. This
residue was initially targeted for study because it resides within the
interior wall of the molecular tunnel leading from the active site of
the small subunit to the first active site of the large subunit. It was
anticipated that a mutation to the larger residue would "clog" the
ammonia tunnel and impede the delivery of ammonia from its site of
production to the site of utilization. In fact, the G359F substitution
resulted in a complete change in the conformation of the loop
delineated by Glu-355 to Ala-364, thereby providing an "escape"
route for the ammonia intermediate directly to the bulk solvent. The
substitution also effected the disposition of several key catalytic
amino acid side chains in the small subunit active site.
The concept of substrate channeling, as described in Ref. 1, was
originally put forth to explain the manner in which reactive intermediates are transferred from one protein to another in a metabolic pathway or shuttled from one active site to another within a
single enzyme. Many have regarded this phenomenon as an essential
mechanism for the regulation of metabolic pathways within the living
cell. Obvious advantages of substrate channeling include the protection
of unstable intermediates or products, the sequestering of toxic
molecules, the control of metabolic flux, the improvement of catalytic
efficiency, and the decreased diffusion of substrates or intermediates
away from their respective active sites. Recent reviews on
the topic of substrate channeling can be found in Refs. 2-4.
While substrate channeling is now a widely accepted concept, there is
still a paucity of mechanistic and structural data pertaining to this
complex biological phenomenon, although this situation is changing
rapidly. The first direct structural observation for substrate
channeling was derived from the elegant x-ray crystallographic analysis
of tryptophan synthase isolated from Salmonella typhimurium (5). This investigation demonstrated that the two active sites located
on the Carbamoyl-phosphate synthetase
(CPS),1 the focus of this
report, catalyzes the production of carbamoyl phosphate, which is subsequently employed in both pyrimidine and arginine biosynthesis in
eukaryotes and prokaryotes. The enzyme from Escherichia coli has been the subject of extensive biochemical analysis for well over
thirty years due, in part, to its interesting catalytic mechanism. Recent reviews of the enzyme can be found in Refs. 11-13. As shown in
Scheme 1, CPS
synthesizes carbamoyl phosphate from two molecules of MgATP, one
molecule of bicarbonate, and one molecule of glutamine using a
catalytic mechanism that proceeds through three reactive intermediates:
carboxy phosphate, ammonia, and carbamate.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
- and
-subunits of the enzyme were separated by a distance
of ~25 Å and connected by a tunnel of the appropriate diameter to
facilitate the diffusion of indole. As more complicated protein
structures are solved to increasingly higher resolution, it is becoming
apparent that substrate channels and tunnels may, indeed, be quite
common. Since the initial x-ray analysis of tryptophan synthase other
examples of enzymes employing substrate channeling have appeared in the
literature including carbamoyl-phosphate synthetase (6), GMP synthetase
(7), glutamine phosphoribosylpyrophosphate amidotransferase (8),
asparagine synthetase (9), and glucosamine-6-phosphate synthase (10),
among others.

View larger version (16K):
[in a new window]
Scheme 1.
As isolated from E. coli, CPS is an
,
-heterodimeric
protein with the individual large and small subunits containing 1073 and 382 amino acid residues, respectively (14, 15). The smaller subunit
catalyzes the hydrolysis of glutamine to glutamate and ammonia and
belongs to the Class I amidotransferase superfamily (16), whereas the
larger subunit harbors the binding sites for both molecules of MgATP,
allosteric ligands such as UMP and ornithine, and various metal ions.
This larger subunit, indeed, contains all of the necessary hardware to
produce carbamoyl phosphate with only ammonia as the nitrogen source
(17).
The recent x-ray crystallographic studies of CPS from E. coli have shed considerable light on this remarkable molecular
machine. As shown in Fig. 1, and quite unexpectedly, the three active
sites of the enzyme are widely spaced throughout the
,
-heterodimer (6, 18-22). By both visual inspection of the CPS
model and the employment of computational searches with the software
package GRASP (23), it was possible to map out a molecular tunnel
connecting the three active sites as indicated in Fig.
1. Accordingly, the ammonia generated by
the small subunit traverses the molecular tunnel leading to the binding
site for the first molecule of MgATP where it reacts with the carboxy
phosphate intermediate to generate carbamate. This particular region
has been referred to as the "ammonia" tunnel and is built from
amino acid residues contributed by both the small subunit and the
N-terminal half of the large subunit. Similarly, the carbamate shuttles
between the first and second MgATP binding sites in the large subunit
in a channel referred to as the carbamate tunnel to generate the final
product, carbamoy phosphate.
|
To test the validity of the molecular tunnel mapped out in the CPS
structure, a series of site-directed mutant proteins were created
within the ammonia tunnel and kinetically studied (24, 25). One
position in particular was targeted for analysis, namely Gly-359 of the
small subunit, which forms an integral part of the interior wall of the
putative molecular tunnel. These investigations demonstrated a direct
correlation between the size of the substituted amino acid and the
extent of the uncoupling of the partial reactions catalyzed by CPS,
specifically glutamine and MgATP hydrolysis. The simplest explanation
for these results was the formation of a blockage within the tunnel
such that ammonia could no longer diffuse from the small subunit to the
first active site of the large subunit. Here we describe the high
resolution structure of one of these mutant proteins, namely the G359F
enzyme. Rather than cause a blockage of the tunnel, the mutation
resulted in the formation of an escape route for ammonia through a path
leading directly to the bulk solvent. The implication of this, with
respect to the evolution of substrate tunnels, is discussed.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Crystallization Procedures--
Protein samples employed for
crystallization trials were purified as previously described (26).
Large single crystals were grown at 4 °C by batch from 8%
polyethylene glycol 8000, 0.65 M tetraethylammonium
chloride, 0.5 mM MnCl2, 100 mM KCl,
1.5 mM ADP, 0.5 mM L-ornithine, and
25 mM HEPPS (pH 7.4). Once the crystals reached dimensions
of ~0.3 mm × 0.3 mm × 0.8 mm, they were flash-frozen according to previously published procedures (6) and stored under
liquid nitrogen until synchrotron beam time became available. The
crystals belonged to the space group
P212121 with unit cell dimensions
of a = 151.1 Å, b = 164.2 Å, and
c = 331.5 Å and one complete
(
,
)4-heterotetramer per asymmetric unit.
X-ray Data Collection and Processing-- An x-ray data set for the G359F mutant protein was collected on a 3 × 3-tiled "SBC2" charge-coupled device detector at the Structural Biology Center 19-ID Beamline (Advanced Photon Source, Argonne National Laboratory). The data were processed with HKL2000 and scaled with SCALEPACK (27). Relevant data collection statistics are presented in Table I.
|
The structure of the G359F mutant protein was solved by Difference
Fourier techniques to a nominal resolution of 2.1 Å. The initial model
was subjected to least-squares refinement with the software package TNT
(28), which reduced the overall R-factor to 26.8%. With
more than 5800 amino acid residues in the asymmetric unit, the goal of
the subsequent model building process was to lower the
R-factor as much as possible using an "averaged"
,
-heterodimer before finally rebuilding the entire
(
,
)4-heterotetramer in the asymmetric unit. Thus, to
expedite the structure refinement process, the electron densities
corresponding to the four
,
-heterodimers in the asymmetric unit
were averaged with the program AVE in the RAVE suite of programs and
the averaged model adjusted according to the map (29, 30). This
averaging and rebuilding process lowered the overall
R-factor to 21.0%. Next the averaged model was used to
create the entire (
,
)4-heterotetramer, which was placed back into the unit cell. Maps were calculated with coefficients of the form (2Fo
Fc), where
Fo was the native structure factor amplitude and
Fc was the calculated structure factor amplitude
from the model, and the four
,
-heterodimers in the asymmetric
unit were adjusted to the electron density using the program TURBO
(31). The final R-factor was 18.0% for all measured x-ray
data. Relevant refinement statistics are given in Table
II. For the sake of simplicity, the
following discussion refers only to the third
,
-heterodimer in the x-ray coordinate file deposited in
the Research Collaboratory for Structural Bioinformatics.
|
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Previous studies have demonstrated that the G359F mutation within the small subunit of CPS results in substantial changes in specific kinetic constants for the modified protein relative to those for the wild-type enzyme. For example, in the partial reaction for the hydrolysis of glutamine (in the absence of ATP), kcat is bigger for the mutant protein than for the wild-type enzyme by about one order of magnitude. However, the Km of glutamine for this reaction is increased by a factor > 400, relative to the wild-type enzyme. Nevertheless, in the presence of ATP/bicarbonate, the maximal rate of glutamine hydrolysis for the mutant protein is essentially the same as for the wild-type enzyme, although the Km for glutamine remains high. These results demonstrate that the catalytic machinery of the G359F mutant protein for the hydrolysis of glutamine is intact and that the enhancement in the rate of glutamine hydrolysis, allosterically induced through the formation of carboxy phosphate within the large subunit of CPS, is fully operational. What has significantly changed with this mutation is the apparent binding affinity for the association of glutamine to the active site within the small subunit.
For the bicarbonate-dependent ATP hydrolysis reaction (in the absence of glutamine) there is a 6-fold increase in the value of kcat for the mutant relative to the wild-type protein. However, there is essentially no increase in the rate of ATP hydrolysis for the G359F mutant protein in the presence of saturating levels of glutamine. The enhanced rate for the partial ATPase reaction (in the absence of glutamine) with the mutant protein is consistent with a greater instability of the carboxy phosphate intermediate apparently due to greater access by solvent water. The abolition of the rate enhancement for ATP turnover in the presence of glutamine for the mutant protein is fully consistent with the impedance of ammonia during delivery to the large subunit. This conclusion is also supported by the diminished rate of synthesis of carbamoyl phosphate while employing glutamine as the nitrogen source. With the mutant protein, the value of kcat/Km for carbamoyl-phosphate synthesis is reduced by 13,000-fold relative to that of the wild-type protein (24) and the overall value of kcat is reduced by a factor of ~60. However, the rate of carbamoyl phosphate formation using ammonia as a nitrogen source is essentially unchanged from the value observed with the wild-type enzyme. Thus, the G359F mutation results in both a significant increase in the Km for glutamine and in the inability of the enzyme to make carbamoyl phosphate using glutamine (but not ammonia) as a nitrogen source. The mutant protein can hydrolyze glutamine and can catalyze the formation of the carboxy phosphate intermediate, but it is unable to couple the reactions catalyzed at the individual active sites toward the production of carbamoyl phosphate.
The question as to whether these alterations to the kinetic constants
are from major structural perturbations of the protein architecture or
rather from a simple blocking of the putative ammonia channel is
addressed here by a high resolution x-ray crystallographic analysis.
The G359F substitution in the small subunit results in virtually no
perturbations in the conformation of the large subunit of the enzyme
and, particularly, within the two MgATP binding pockets. Indeed, the
-carbons alone or all atoms comprising the large subunit of the
mutant protein superimpose onto the wild-type enzyme with root mean
square deviations of 0.25 and 1.20 Å, respectively.
The situation is more complex, however, with regard to the small
subunit and to its active site region. The
-carbons alone or all
atoms comprising the small subunit of the mutant protein superimpose
onto the wild-type enzyme with root mean square deviations of 1.05 and
1.20 Å, respectively. Shown in Fig. 2 is
a superposition of the wild-type and G359F mutant proteins near the
glutaminase active site of the small subunit. In the wild-type enzyme,
as in all Class I amidotransferases examined to date, Cys-269 and His-353 (or their structural equivalents) function as a catalytic couple with His-353 serving to deprotonate the side chain thiol of
Cys-269. Additionally, there is a conserved glutamate in the Class I
amidotransferases, namely Glu-355 in CPS, which hydrogen bonds to the imidazole group of His-353. In wild-type CPS,
O
1of Glu-355 lies within 2.9 Å from N
1
of His-353. Most likely Glu-355 plays a key role in correctly positioning the side chain of His-353 for effective deprotonation of
Cys-269. The mutation of Glu-355 to an alanine residue, however, has no
effect on the maximal rate of glutamine hydrolysis but does result in
an order of magnitude increase in the Km for
glutamine (32). Upon substituting a glycine with a phenylalanine residue at position 359, the polypeptide chain in the nearby vicinity adopts a quite different conformation as can be seen in Fig. 2. The net
result is that the carboxylate group of Glu-355 is no longer within
hydrogen bonding distance to His-353 but rather is positioned at ~8.0
Å away. Additionally, the side chain O
1 of Asn-311,
which normally hydrogen bonds to N
1 of His-291, rotates
by ~159 ° and ~60 ° about the C
/C
and C
/C
bonds,
respectively, thereby allowing it to interact with N
1 of
His-353 (3.2 Å). This distance in wild-type CPS is ~5.5 Å.
|
The path of the ammonia tunnel in native CPS is outlined in Fig.
3a. Gly-359 of the small
subunit is positioned within the random coil area delineated by Glu-355
to Ala-364, and it is this region that provides one side of the ammonia
tunnel. The goal of the G359F mutation was to block this conduit for
the passage of ammonia, and, indeed, the observed kinetics parameters
for the G359F mutant protein clearly indicate the importance of this region for communication between active sites and for the ultimate synthesis of carbamoyl phosphate. Unexpectedly, however, the G359F mutation resulted in a change in conformation for this random coil
region beginning at Pro-354. Electron density corresponding to this
region in the G359F mutant protein is displayed in Fig. 4. Note that the region of the
polypeptide chain from Phe-359 (the site of the mutation) to Asp-363 is
disordered in the electron density map. In wild-type CPS, Pro-354
adopts torsional angles of
=
70 ° and
=
21 °. In the G359F mutant protein, these torsional angles are
=
56 ° and
= 145 ° with the net effect of
opening up one side of the ammonia tunnel and sending the polypeptide chain off into an extended conformation. The distance between the
prolines at position 358 in the two structures is ~13 Å. This change
at Pro-354 could not have been predicted given that in the wild-type
enzyme the
-carbons for Pro-354 and Gly-359 are separated by ~9
Å. As a result of the changes in the polypeptide chain conformation
between Glu-355 and Ala-364, the structural integrity of the ammonia
tunnel has been compromised and an accompanying new "escape route"
for the ammonia intermediate has been formed as indicated in Fig.
3b. This escape route undoubtedly contributes to the
uncoupling of the separate chemical reactions in the G359F mutant form
of CPS.
|
|
One of the more intriguing questions concerning enzymes that employ substrate channeling in their reaction mechanisms is the manner in which these molecular tunnels first evolved. There are examples in the literature, such as CPS and tryptophan synthetase (5), whereby the molecular channels are fully formed even in the absence of a full complement of substrates. In some enzymes, though, it appears as if the channels only exist transiently during each catalytic cycle such as in glutamine phosphoribosylpyrophosphate amidotransferase (8). For those enzymes containing permanent substrate channels, two possible mechanisms for tunnel evolution can be envisioned. In one scenario, smaller amino acid residues are substituted for larger side chains, thereby creating incremental cavities throughout the interior of the protein that eventually merge into a tunnel connecting active sites. The difficulty with this scenario, however, is that the creation of cavities within the interior of a protein has been demonstrated to have, in general, a destabilizing effect (33). Another mechanism of channel formation that can be envisioned involves single point mutations where smaller amino acid residues within the interior of a enzyme are substituted with larger side chains, thereby leading to substantial conformational changes in the protein architecture. Although most of these changes would be disruptive and lead to a loss of proper folding or catalytic activity, it would be expected that some could give rise to the formation of new tunnels. This second scenario seems more likely since, as demonstrated in this investigation, single point mutations can have profound effects on the polypeptide chain conformation far from the original site of the substitution.
In summary, as has been so often the case in other protein
site-directed mutagenesis studies, the replacement of a single amino
acid in the ammonia tunnel of CPS resulted in changes in its
three-dimensional architecture that could not have been anticipated. Rather than "clog" the ammonia tunnel, the G359F mutation resulted both in the formation of a new pathway for ammonia dispersion and in
altered conformations of key catalytic residues within the glutaminase
active site of the small subunit. The fact that the G359F mutation
affects the synchronization of the active sites required for glutamine
and MgATP hydrolysis lends further experimental support for the
functional existence of the ammonia tunnel in CPS.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. W. W. Cleland for carefully reading this manuscript.
| |
FOOTNOTES |
|---|
* This research was supported in part by National Institutes of Health Grants GM55513 (to H. M. H.) and DK30343 (to F. M. R.) and the Robert A. Welch Foundation Grant A840. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the United States Department of Energy, Office of Energy Research under contract no. W-31-109-ENG-38.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1M6V) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
¶ Present address: Wyeth Research, Dept. of Biological Chemistry, 401 N. Middleton Rd., Pearl River, NY 10923.
To whom correspondence may be addressed. Tel.: 979-845-3373;
Fax: 979-845-9452; E-mail: Raushel@tamu.edu.
** To whom correspondence may be addressed. Tel.: 608-262-4988; Fax: 608-262-1319; E-mail: Hazel_Holden@biochem.wisc.edu.
Published, JBC Papers in Press, July 18, 2002, DOI 10.1074/jbc.M206915200
| |
ABBREVIATIONS |
|---|
The abbreviation used is: CPS, carbamoyl-phosphate synthetase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Srere, P. A. (1987) Annu. Rev. Biochem. 56, 89-124[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Anderson, K. S. (1999) Methods Enzymol. 308, 111-145[Medline] [Order article via Infotrieve] |
| 3. | Spivey, H. O., and Ovadi, J. (1999) Methods 19, 306-321[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Huang, X., Holden, H. M., and Raushel, F. M. (2001) Annu. Rev. Biochem. 70, 149-180[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Hyde, C. C.,
Ahmed, S. A.,
Padlan, E. A.,
Miles, E. W.,
and Davies, D. R.
(1988)
J. Biol. Chem.
263,
17857-17871 |
| 6. | Thoden, J. B., Holden, H. M., Wesenberg, G., Raushel, F. M., and Rayment, I. (1997) Biochemistry 36, 6305-6316[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Tesmer, J. J. G., Klem, T. J., Deras, M. L., Davisson, V. J., and Smith, J. L. (1996) Nat. Struct. Biol. 3, 74-86[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Krahn, J. M., Kim, J. H., Burns, M. R., Parry, R. J., Zalkin, H., and Smith, J. L. (1997) Biochemistry 36, 11061-11068[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Larsen, T. M., Boehlein, S. K., Schuster, S. M., Richards, N. G. J., Thoden, J. B., Holden, H. M., and Rayment, I. (1999) Biochemistry 38, 16146-16157[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Teplyakov, A., Obmolova, G., Badet, B., and Badet-Denisot, M. A. (2001) J. Mol. Biol. 313, 1093-1102[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Raushel, F. M., Thoden, J. B., Reinhart, G. D., and Holden, H. M. (1998) Curr. Opin. Chem. Biol. 5, 624-632 |
| 12. | Holden, H. M., Thoden, J. B., and Raushel, F. M. (1998) Curr. Opin. Struct. Biol. 8, 679-685[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Holden, H. M., Thoden, J. B., and Raushel, F. M. (1999) Cell Mol. Life Sci. 56, 507-522[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Piette, J.,
Nyunoya, H.,
Lusty, C. J.,
Cunin, R.,
Weyens, G.,
Crabeel, M.,
Charlier, D.,
Glansdorff, N.,
and Piérard, A.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4134-4138 |
| 15. |
Nyunoya, H.,
and Lusty, C. J.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
4629-4633 |
| 16. |
Rubino, S. D.,
Nyunoya, H.,
and Lusty, C. J.
(1986)
J. Biol. Chem.
261,
11320-11327 |
| 17. |
Trotta, P. P.,
Burt, M. E.,
Haschemeyer, R. H.,
and Meister, A.
(1971)
Proc. Natl. Acad. Sci. U. S. A.
68,
2599-2603 |
| 18. | Thoden, J. B., Miran, S. G., Phillips, J. C., Howard, A. J., Raushel, F. M., and Holden, H. M. (1998) Biochemistry 37, 8825-8831[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Thoden, J. B., Raushel, F. M., Benning, M. M., and Holden, H. M. (1999) Acta Crystallogr. Sect. D Biol. Crystallogr. 55, 8-24[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Thoden, J. B., Wesenberg, G., Raushel, F. M., and Holden, H. M. (1999) Biochemistry 38, 2347-2357[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Thoden, J. B,
Raushel, F. M.,
Wesenberg, G.,
and Holden, H. M.
(1999)
J. Biol. Chem.
274,
22502-22507 |
| 22. | Thoden, J. B., Huang, X., Raushel, F. M., and Holden, H. M. (1999) Biochemistry 38, 16158-16166[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Nicholls, A., Sharp, K. A., and Honig, B. (1991) Proteins Struct. Funct. Genet. 11, 281-296 |
| 24. | Huang, X., and Raushel, F. M. (2000) Biochemistry 39, 3240-3247[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Huang, X.,
and Raushel, F. M.
(2000)
J. Biol. Chem.
275,
26233-26240 |
| 26. | Miran, S. G., Chang, S. H., and Raushel, F. M. (1991) Biochemistry 30, 7901-7907[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326 |
| 28. | Tronrud, D. E., Ten Eyck, L. F., and Matthews, B. W. (1987) Acta Crystallogr. Sect. A. 43, 489-501 |
| 29. | Jones, T. A. (1992) in Molecular Replacement (Dodson, E. J. , Gover, S. , and Wolf, W., eds) , pp. 91-105, SERC Daresbury Laboratory, Warrington, England |
| 30. | Kleywegt, G. J., and Jones, T. A. (1994) in From First Map to Final Model (Bailey, S. , Hubbard, R. , and Waller, D., eds) , pp. 59-66, SERC Daresbury Laboratory, Warrington, England |
| 31. | Roussel, A., Fontecilla-Camps, J. C., and Cambillau, C. (1990) Acta Crystallogr. Sect. A 46, C66-C67 |
| 32. | Huang, X., and Raushel, F. M. (1999) Biochemistry 38, 15909-15914[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Matthews, B. W. (1996) FASEB J. 10, 35-41[Abstract] |
| 34. | Kraulis, P. J. (1991) J. Appl. Cryst. 24, 946-950 |
This article has been cited by other articles:
![]() |
K. Abdurachim and H. R. Ellis Detection of Protein-Protein Interactions in the Alkanesulfonate Monooxygenase System from Escherichia coli J. Bacteriol., December 1, 2006; 188(23): 8153 - 8159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Thoden, X. Huang, J. Kim, F. M. Raushel, and H. M. Holden Long-range allosteric transitions in carbamoyl phosphate synthetase Protein Sci., September 1, 2004; 13(9): 2398 - 2405. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |